Data, which come from a study by Stamey et al. (1989), examining the correlation between the level of prostate-specific antigen (PSA) and various clinical measures in men who were about to receive a radical prostatectomy.
pcancerA data frame with 97 rows and 9 variables:
log(cancer volume (cm^3))
log(prostate weight (g))
age of the patient
log(amount of benign prostatic hyperplasia (cm^2))
presence of seminal vesicle invasion (1=yes, 0=no)
log(capsular penetration (cm))
Gleason score
percentage of Gleason scores four of five
log(PSA (ng/mL))
Stamey, T. A., Kabalin, J. N., McNeal, J. E., Johnstone, I. M., Freiha, F., Redwine, E. A., and Yang, N. (1989). Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. ii. radical prostatectomy treated patients. The Journal of urology, 141(5):1076-1083.